News
-
-
-
-
PRESS RELEASE
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio, for upfront amount of USD 600 million, plus potential milestones
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio for $600 million upfront plus potential milestones, enhancing HBM Healthcare Investments -
-
-
-
-
-